Reduced death rates from colorectal cancer with FIT screening
An analysis of Kaiser Permanente patients in California found a 33% reduced risk of dying from colorectal cancer among those completing at least one at-home fecal immunochemical test (FIT) screening. The study was published in JAMA Network Open. In 2007, Kaiser Permanente Southern California began ...
Featured News
Program helping patients lower cholesterol nets international award
A 2019 Kaiser Permanente program has helped patients with high levels of “bad cholesterol” start taking medications to lower their cholesterol and decrease their risk of stroke and heart attacks. ...
Five questions for … Dr. Michael Kanter
Dr. Michael Kanter is an associate investigator with the Department of Research & Evaluation and the chair of Clinical Science and a professor for the Kaiser Permanente Bernard J. Tyson School ...
Eating raw vegetables may improve bladder cancer outcomes
Non-muscle invasive bladder cancer patients whose treatment included the immunotherapy Bacillus Calmette-Guerin (BCG) after surgery were less likely to have their cancer recur if their diet included ...
Some patients take 2nd at-home fecal test to delay colonoscopy
May 22, 2024A study of 316,443 patients shows that 7.4% of patients repeated fecal testing rather than proceeding directly to colonoscopy as guidelines recommend, and of those who repeated home tests, over half did not have a colonoscopy within one year. Colorectal cancer is the second most common cancer-related cause of death in the United States, but screening ...Read more...Study suggests waning protection from Moderna bivalent COVID-19 vaccine
May 15, 2024Emerging COVID-19 variants continue to cause serious COVID-19 disease, but most people have not received any COVID-19 vaccine for more than a year. Kaiser Permanente Southern California researchers assessed the effectiveness of bivalent COVID-19 vaccines against the recently circulating variants or sublineages to inform policymakers and the potential need for updated vaccines. One of the latest studies found ...Read more...Study sheds light on needs of young people who survive cancer
May 3, 2024Emergency department use was common for adolescent and young adult cancer survivors within 5 years of a cancer diagnosis, and differences in use were associated with social and demographic factors and cancer type, according to a new Kaiser Permanente study. The American Cancer Society reports that more young people are being diagnosed with cancer. Understanding their ...Read more...Five questions for … Dr. Huong Nguyen
May 3, 2024A nurse and health services researcher, Huong Q. Nguyen, PhD, RN, focuses her research on the care of older adults with chronic and serious illnesses. She is the co-lead of the Care Improvement Research Team and interim director of the Division of Health Services Research & Implementation for the Department of Research & Evaluation. She ...Read more...Q&A with Physician Researcher of the Year: Dr. Michael Fassett
February 7, 2024Michael J. Fassett, MD, came to work at Kaiser Permanente in 2000. Since then, his dedication to his patients through research has grown. He’s published more than 50 research papers in peer-reviewed journals. Now, as the regional physician-in-charge for Maternal-Fetal Medicine and the area research chair for the West Los Angeles and Kern County service ...Read more...Five questions for … Dr. Annette Langer-Gould
December 20, 2023Annette Langer-Gould, MD, PhD, is a translational neuroscientist with the Southern California Permanente Medical Group. She treats people with multiple sclerosis (MS) at the Kaiser Permanente Los Angeles Medical Center. Dr. Langer-Gould joined Kaiser Permanente in 2009. Her research aims to deepen understanding of MS while improving quality of care. Recently, she co-authored an editorial in ...Read more...COVID bivalent booster protects well against hospitalization
December 4, 2023A Kaiser Permanente study shows the Pfizer-BioNTech BNT162b2 BA.4/5 bivalent mRNA vaccine helped protect against a range of COVID symptoms and was effective against the COVID XBB strain sublineages. The most substantial benefit of the bivalent vaccine booster was keeping people out of the hospital and keeping people from becoming critically ill. The study was ...Read more...Kaiser Permanente Southern California to lead CDC-funded center to improve outbreak and disease prediction
October 18, 2023Kaiser Permanente Southern California has been tapped to lead an innovation center that will develop advanced modeling approaches to better predict disease outbreaks and prepare the United States for future public health emergencies. The center is 1 of 13 sites that will form the Outbreak Analytics and Disease Modeling Network, a national initiative funded by the ...Read more...Diabetes increased among kids during pandemic
September 25, 2023A study of more than 1 million Kaiser Permanente members ages 19 and younger found that rates of both type 1 and type 2 diabetes increased among children during the COVID-19 pandemic, particularly for those ages 10 and older, male children, and children in specific racial and ethnic groups. The study was published September 21, ...Read more...Kaiser Permanente cancer survival rates higher
September 25, 2023Kaiser Permanente had better 5-year survival rates among breast, colorectal, and lung cancer patients compared to the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) estimates, according to research published in September 2023 in The Permanente Journal. Researchers in all 8 Kaiser Permanente regions worked together on this study. They compared the occurrence of cancer ...Read more...